Effects of interferon inducing agents (polyriboinosinic acid. Polyribocytidylic acid, tilorone) on hepatic hemoproteins (cytochrome P-450, catalase, tryptophan 2,3-dioxygenase, mitochondrial cytochromes), heme metabolism and cytochrome P-450-linked monooxygenase systems.
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000818:Animals; D001579:Benzopyrene Hydroxylase / Q000378:metabolism; D002374:Catalase / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003580:Cytochromes / Q000378:metabolism; D005037:Ethylmorphine-N-Demethylase / Q000378:metabolism; D005449:Fluorenes / Q000494:pharmacology*; D006418:Heme / Q000378:metabolism*; D006420:Hemeproteins / Q000378:metabolism*; D066298:In Vitro Techniques; D007369:Interferon Inducers / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism*; D011070:Poly I-C / Q000494:pharmacology*; D051381:Rats; D013994:Tilorone / Q000494:pharmacology*; D014366:Tryptophan Oxygenase / Q000378:metabolism
D003580:Cytochromes; D005449:Fluorenes; D006420:Hemeproteins; D007369:Interferon Inducers; D006418:Heme; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D002374:Catalase; D014366:Tryptophan Oxygenase; D001579:Benzopyrene Hydroxylase; D005037:Ethylmorphine-N-Demethylase; D000624:5-Aminolevulinate Synthetase; D013994:Tilorone; D011070:Poly I-C